Vapotherm Blog

Rethinking Ventilation—Do you always need pressure?

Rethinking Ventilation—Do you always need pressure? The frequent-flyer COPDer comes into the hospital, dyspneic and tripoding and the respiratory therapist is readying the non-invasive positive pressure ventilation (NiPPV)—this is a frequent sight for clinicians admitting respiratory distress patients. NiPPV has been the gold standard treatment for patients with hypercapnia. It reduces the risks associated with

Five Reasons Your Hospital Should Try High Velocity Nasal Insufflation

High Velocity Nasal Insufflation (HVNI) is Mask-Free Noninvasive Ventilation pioneered by Vapotherm® for the treatment of undifferentiated respiratory distress in spontaneously breathing patients. Here are a few benefits that hospitals, clinicians, and their patients may experience with this breakthrough at the frontlines of respiratory care. 1. Clinical Efficacy of NiPPV, but Without the Mask Intubation

FDA Grants Vapotherm’s De Novo Request for New Category for Precision Flow Hi-VNI System

The U.S. Food and Drug Administration (FDA) granted Vapotherm’s request for a new category (QAV), and expanded indications for the latest version Precision Flow, the Precision Flow Hi-VNITM system. The indication now states this system may be used to augment breathing of spontaneously breathing patients suffering from respiratory distress in the acute setting. This indication

What is Mask-Free NIV?

For patients in respiratory distress, non-invasive positive pressure ventilation (NiPPV) has been the first-line approach for decades. It’s a respected standard of care, but not all patients can tolerate this mask-based therapy. Facial hair that prevents a seal, nausea that creates an aspiration risk, mask anxiety, and discomfort are just a few reasons patients cannot

How to Select Clinically Effective Liter Flows for Hypercapnic Patients?

Vapotherm’s Hi-VNI® Technology can be used to treat respiratory distress in hospital settings. Vapotherm does not practice medicine or provide medical services. These guidelines are based on an assessment of peer-reviewed published literature, physician interviews, and physiological modeling. Providers should refer to the full indications for use, operating instructions, and prescribing information of any products

ICU

New Randomized Controlled Trial Recommends Vapotherm High Velocity Therapy as Front-Line Tool for Patients Admitted to ICU with Severe Bronchiolitis

Vapotherm’s high velocity therapy is a tool for treating respiratory distress in patients for whom prescribers desire to add heat and moisture to breathing gases. This webpage contains links to third party abstracts and/or publications that describe certain outcomes in relation to the use of Vapotherm’s Hi-VNI® Technology, but individual results may vary. Practitioners should

Study Suggests Sedation May Prevent NIV Failure, but Continuous Sedation May Increase Mortality in DNI Patients

Vapotherm’s Hi-VNI® Technology is a tool for treating respiratory distress in patients for whom prescribers desire to add heat and moisture to breathing gases. This webpage contains links to third party abstracts and/or publications that describe certain outcomes in relation to the use of Vapotherm’s Hi-VNI® Technology, but individual results may vary. Practitioners should refer

Dexmedetomidine During Noninvasive Ventilation: Dr. Shein from Rainbow Babies and Children’s Hospital Cleveland, OH Comments

Vapotherm’s Hi-VNI® Technology is a tool for treating respiratory distress in patients for whom prescribers desire to add heat and moisture to breathing gases. This webpage contains links to third party abstracts and/or publications that describe certain outcomes in relation to the use of Vapotherm’s Hi-VNI® Technology, but individual results may vary. Practitioners should refer

New Study Finds 33% Mortality Rate for Older Adults After Intubation

Vapotherm’s Hi-VNI® Technology is a tool for treating respiratory distress in patients for whom prescribers desire to add heat and moisture to breathing gases. This webpage contains links to third party abstracts and/or publications that describe certain outcomes in relation to the use of Vapotherm’s Hi-VNI® Technology, but individual results may vary. Practitioners should refer

New Meta-Analysis Shows NIV Achieves Survival without Decrease of Life Quality for Patients on DNI Orders

Vapotherm’s Hi-VNI® Technology is a tool for treating respiratory distress in patients for whom prescribers desire to add heat and moisture to breathing gases. This webpage contains links to third party abstracts and/or publications that describe certain outcomes in relation to the use of Vapotherm’s Hi-VNI® Technology, but individual results may vary. Practitioners should refer